Bloomberg Money Minute: Retail Earnings, Ozempic Price Drop, and Thoma Bravo's Acquisition Interest

Retail Earnings and Economic Signals

• 🎯 Retail earnings are a major focus this week, with reports expected from major companies like Wal-Mart, Home Depot, Target, and Lowe's.
• 📈 Investors will also be closely monitoring signals from the Federal Reserve regarding interest rates.
• 🕊️ Efforts to secure a peace deal for Ukraine are also on the agenda.

Ozempic Price Reduction

• 💊 Novo Nordisk has announced a price reduction for Ozempic, making the diabetes medication available for $499 a month through their Novo Care pharmacy.
• 🤝 The company is also partnering with GoodRx to offer Ozempic and the weight loss drug Wegovy at the same price across U.S. pharmacies.
• 🗣️ This move follows pressure from President Donald Trump on drug companies to lower prices.

Thoma Bravo's Acquisition Interest

• 💰 Sources indicate that the buyout firm Thoma Bravo is in talks to acquire Dayforce.
• 💻 Dayforce is an HR software provider serving industries such as health care, retail, hospitality, and financial services.

Market Opening

• 📊 Stocks opened narrowly mixed on Monday.